Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Jag2 is essential for proper skin cell differentiation and organization.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Canine hair follicle cells show stem cell properties, aiding hair growth.

Cells that move well may improve hair loss treatments by entering hair follicles.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

SETDB1 is essential for controlling DNA methylation, silencing retrotransposons, and maintaining skin cell health, with its absence leading to skin inflammation and hair loss.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Interleukin 6 may help protect skin without causing inflammation.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Mice with too much Claudin-6 have skin barrier problems and abnormal hair growth.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

K6hf is a unique protein found only in a specific layer of hair follicles.

The new Hairless R/J mice model improves imaging for tumor monitoring and cancer therapy evaluation.

Overexpression of IKZF1 and Ikaros causes hair loss in mice similar to alopecia areata.

Cell adhesion molecules are important in the development of certain skin diseases.

Immune activation of hair follicle stem cells can help develop new hair regeneration therapies.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Bipotent dermal stem cells and specific macrophages are crucial for hair regrowth and regeneration.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

DHA derivatives, especially didocosahexaenoin, effectively kill prostate cancer cells and may offer a safer cancer treatment option.

CXCR2 in skin cells promotes tumor growth.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Epigenetic changes in blood cells may contribute to alopecia areata.